12:00 AM
 | 
Oct 10, 2001
 |  BC Extra  |  Company News

Pharmos sells ophthalmics to BOL

PARS sold its loteprednol etabonate (LE) ophthalmic business to Bausch & Lomb (BOL). BOL paid $25 million in cash for PARS's Lotemax...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >